These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 21305525)

  • 61. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.
    Hoffman GS; Cid MC; Hellmann DB; Guillevin L; Stone JH; Schousboe J; Cohen P; Calabrese LH; Dickler H; Merkel PA; Fortin P; Flynn JA; Locker GA; Easley KA; Schned E; Hunder GG; Sneller MC; Tuggle C; Swanson H; Hernández-Rodríguez J; Lopez-Soto A; Bork D; Hoffman DB; Kalunian K; Klashman D; Wilke WS; Scheetz RJ; Mandell BF; Fessler BJ; Kosmorsky G; Prayson R; Luqmani RA; Nuki G; McRorie E; Sherrer Y; Baca S; Walsh B; Ferland D; Soubrier M; Choi HK; Gross W; Segal AM; Ludivico C; Puechal X;
    Arthritis Rheum; 2002 May; 46(5):1309-18. PubMed ID: 12115238
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Efficacy of early treatment of severe juvenile dermatomyositis with intravenous methylprednisolone and methotrexate.
    Al-Mayouf S; Al-Mazyed A; Bahabri S
    Clin Rheumatol; 2000; 19(2):138-41. PubMed ID: 10791626
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Low effectiveness of methotrexate in the management of localised scleroderma (morphea) based on an ultrasound activity score.
    Vera-Kellet C; Meza-Romero R; Moll-Manzur C; Ramírez-Cornejo C; Wortsman X
    Eur J Dermatol; 2021 Dec; 31(6):813-821. PubMed ID: 35107072
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A randomized placebo-controlled double-blind pilot study of methotrexate in the treatment of H1 antihistamine-resistant chronic spontaneous urticaria.
    Sharma VK; Singh S; Ramam M; Kumawat M; Kumar R
    Indian J Dermatol Venereol Leprol; 2014; 80(2):122-8. PubMed ID: 24685847
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of mycophenolate mofetil vs. methotrexate for the treatment of chronic plaque psoriasis.
    Akhyani M; Chams-Davatchi C; Hemami MR; Fateh S
    J Eur Acad Dermatol Venereol; 2010 Dec; 24(12):1447-51. PubMed ID: 20384673
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Preliminary evidence on abatacept safety and efficacy in refractory juvenile localized scleroderma.
    Li SC; Torok KS; Ishaq SS; Buckley M; Edelheit B; Ede KC; Liu C; Rabinovich CE
    Rheumatology (Oxford); 2021 Aug; 60(8):3817-3825. PubMed ID: 33369667
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Long-term follow-up of polymyalgia rheumatica patients treated with methotrexate and steroids.
    Cimmino MA; Salvarani C; Macchioni P; Gerli R; Bartoloni Bocci E; Montecucco C; Caporali R;
    Clin Exp Rheumatol; 2008; 26(3):395-400. PubMed ID: 18578959
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Oral versus intramuscular methotrexate in juvenile chronic arthritis. Italian Pediatric Rheumatology Study Group.
    Ravelli A; Gerloni V; Corona F; Falcini F; Lepore L; De Sanctis R; Zulian F; Buoncompagni A; Sardella ML; Strano CG; Alessio M; Fantini F; Bardare M; Martini A
    Clin Exp Rheumatol; 1998; 16(2):181-3. PubMed ID: 9536397
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical Profile of Methotrexate-resistant Juvenile Localised Scleroderma.
    Hardy J; Boralevi F; Mallet S; Cabrera N; Belot A; Phan A; Barbarot S; Duriez-Lasek A; Chiaverini C; Hubiche T; Mahé E; Bégon E; Bourrat E; Boccara O; Aubert H; Lerosey MG; Droitcourt C; Piram M; Mazereeuw-Hautier J;
    Acta Derm Venereol; 2019 May; 99(6):539-543. PubMed ID: 30810215
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Linear morphea: a case series with long-term follow-up of young, methotrexate-treated patients.
    Koch SB; Cerci FB; Jorizzo JL; Krowchuk DP
    J Dermatolog Treat; 2013 Dec; 24(6):435-8. PubMed ID: 23758214
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A prospective, double-blind, randomized, placebo controlled trial of methotrexate in the treatment of giant cell arteritis (GCA).
    Spiera RF; Mitnick HJ; Kupersmith M; Richmond M; Spiera H; Peterson MG; Paget SA
    Clin Exp Rheumatol; 2001; 19(5):495-501. PubMed ID: 11579707
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Determinants for drug survival of methotrexate in patients with psoriasis, split according to different reasons for discontinuation: results of the prospective MTX-CAPTURE.
    Otero ME; van den Reek JM; Seyger MM; van de Kerkhof PC; Kievit W; de Jong EM
    Br J Dermatol; 2017 Aug; 177(2):497-504. PubMed ID: 28078672
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Placebo controlled trial of methotrexate in systemic sclerosis.
    Das SN; Alam MR; Islam N; Rahman MH; Sutradhar SR; Rahman S; Khan GK; Rahim A; Haq SA
    Mymensingh Med J; 2005 Jan; 14(1):71-4. PubMed ID: 15695960
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Prednisone plus methotrexate for polymyalgia rheumatica: a randomized, double-blind, placebo-controlled trial.
    Caporali R; Cimmino MA; Ferraccioli G; Gerli R; Klersy C; Salvarani C; Montecucco C;
    Ann Intern Med; 2004 Oct; 141(7):493-500. PubMed ID: 15466766
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Methotrexate as a single agent for treating pulmonary sarcoidosis: a single centre real-life prospective study.
    Goljan-Geremek A; Bednarek M; Franczuk M; Puścińska E; Nowiński A; Czystowska M; Kamiński D; Korzybski D; Stokłosa A; Kowalska A; Wojda E; Sliwiński P; Burakowska B; Ptak J; Barańska I; Drygalska A; Małek G; Bestry I; Wesołowski S; Kram M; Górecka D
    Pneumonol Alergol Pol; 2014; 82(6):518-33. PubMed ID: 25339562
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial.
    Ruperto N; Pistorio A; Oliveira S; Zulian F; Cuttica R; Ravelli A; Fischbach M; Magnusson B; Sterba G; Avcin T; Brochard K; Corona F; Dressler F; Gerloni V; Apaz MT; Bracaglia C; Cespedes-Cruz A; Cimaz R; Couillault G; Joos R; Quartier P; Russo R; Tardieu M; Wulffraat N; Bica B; Dolezalova P; Ferriani V; Flato B; Bernard-Medina AG; Herlin T; Trachana M; Meini A; Allain-Launay E; Pilkington C; Vargova V; Wouters C; Angioloni S; Martini A;
    Lancet; 2016 Feb; 387(10019):671-678. PubMed ID: 26645190
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Use of Mycophenolate Mofetil in Patients with Severe Localized Scleroderma Resistant or Intolerant to Methotrexate.
    Mertens JS; Marsman D; van de Kerkhof PC; Hoppenreijs EP; Knaapen HK; Radstake TR; de Jong EM; Seyger MM
    Acta Derm Venereol; 2016 May; 96(4):510-3. PubMed ID: 26582717
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Psychological side effects of MTX treatment in juvenile idiopathic arthritis: a pilot study.
    van der Meer A; Wulffraat NM; Prakken BJ; Gijsbers B; Rademaker CM; Sinnema G
    Clin Exp Rheumatol; 2007; 25(3):480-5. PubMed ID: 17631750
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Adverse Effects of Low-Dose Methotrexate: A Randomized Trial.
    Solomon DH; Glynn RJ; Karlson EW; Lu F; Corrigan C; Colls J; Xu C; MacFadyen J; Barbhaiya M; Berliner N; Dellaripa PF; Everett BM; Pradhan AD; Hammond SP; Murray M; Rao DA; Ritter SY; Rutherford A; Sparks JA; Stratton J; Suh DH; Tedeschi SK; Vanni KMM; Paynter NP; Ridker PM
    Ann Intern Med; 2020 Mar; 172(6):369-380. PubMed ID: 32066146
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study.
    Li SC; Fuhlbrigge RC; Laxer RM; Pope E; Ibarra MF; Stewart K; Mason T; Becker ML; Hong S; Dedeoglu F; Torok KS; Rabinovich CE; Ferguson PJ; Punaro M; Feldman BM; Andrews T; Higgins GC;
    Pediatr Rheumatol Online J; 2019 Jul; 17(1):43. PubMed ID: 31307476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.